Please assess the completion status of the following clinical trial:

Trial Title: Study to Investigate the Long-term Safety of FAB122 in Patients With Amyotrophic Lateral Sclerosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. who completed the full study period in the main ADORE study (FAB122-CT-2001);~2. whom the investigator has no concern and judges tolerable for initiating or continuing treatment with FAB122 from a risk and benefit point of view;~3. a female subject should not be able to become pregnant up to 30 days after the last dose of FAB122 and needs to meet at least one of the following criteria:~   * female who is of reproductive potential and has a negative pregnancy test at baseline and is non-lactating.~  * female subject who is not of reproductive potential is eligible without requiring the use of contraception~4. a male patient must:~   * agree he will not donate sperm during the period he will be using FAB122, AND use a condom during sexual intercourse with pregnant or non-pregnant women of childbearing potential~Exclusion Criteria:~1. Patient who has a medical condition or personal circumstances which, in the opinion of the investigator, will make initiation or continuation of treatment with FAB122 not tolerable for them from a risk and benefit point of view.~2. Patient who discontinued study drug prematurely in the double-blind phase of the study (ADORE Study) for safety reasons.~3. Patient who has received any other investigational drug within the period between last visit of the main study and first visit of the extension study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Open Label (Type: EXPERIMENTAL): Drug: FAB122 Daily dose 100 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).